iBio, Inc. (IBIO)
CIK 1420720 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 49.7M shares as of May 12, 2026 (10-Q). Share count fell from 218.2M to 9.0M between May 9, 2022 and Oct 10, 2022, a pattern consistent with a reverse split (roughly 1-for-24); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Pre Funded Warrants | 89.0M | $0.001 | — | — |
| Series H Warrants | 35.8M | not tagged | 4y | — |
| Series G Warrants | 35.8M | not tagged | 5y | — |
| Pre Funded Series G Warrants | 35.8M | not tagged | — | — |
| Pre Funded Series H Warrants | 35.8M | not tagged | — | — |
| Pre Funded Warrants2026 | 9.7M | $0.001 | — | — |
| Existing Warrants | 5.6M | $0.86 | — | — |
| Series E Warrants | 3.5M | $0.86 | 5y | — |
| Pre Funded Warrants2024 | 2.6M | $0.0001 | — | — |
| Series C Warrants | 2.3M | $2 | 2y | — |
| Series D Warrants | 2.3M | $2 | 5y | — |
| Series C and D Warrants | 2.0M | $0.86 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 12, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 0 underlying shares, as reported Jun 30, 2021 (10-K).
Reported exercise price: $0.0001 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 49.7M = 49.7M O/S + 0 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 12, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 49.7M | May 12, 2026 |
| + Pre Funded Warrants (if exercised) | 89.0M | Mar 31, 2026 |
| + Series H Warrants (if exercised) | 35.8M | Aug 19, 2025 |
| + Series G Warrants (if exercised) | 35.8M | Aug 19, 2025 |
| + Pre Funded Series G Warrants (if exercised) | 35.8M | Aug 19, 2025 |
| + Pre Funded Series H Warrants (if exercised) | 35.8M | Aug 19, 2025 |
| + Pre Funded Warrants2026 (if exercised) | 9.7M | Jan 8, 2026 |
| + Existing Warrants (if exercised) | 5.6M | Apr 29, 2025 |
| + Series E Warrants (if exercised) | 3.5M | Apr 29, 2025 |
| + Pre Funded Warrants2024 (if exercised) | 2.6M | Mar 26, 2024 |
| + Series C Warrants (if exercised) | 2.3M | Dec 7, 2023 |
| + Series D Warrants (if exercised) | 2.3M | Dec 7, 2023 |
| + Series C and D Warrants (if exercised) | 2.0M | Apr 29, 2025 |
| Fully diluted estimate | 309.6M | +523.3% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $226.1Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 4 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full IBIO workspace